Fingerprint
Dive into the research topics of 'A Phase II Trial of Aprinocarsen, an Antisense Oligonucleotide Inhibitor of Protein Kinase C α, Administered as a 21-Day Infusion to Patients with Advanced Ovarian Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically